Results 201 to 210 of about 375,685 (295)

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

open access: yesHead &Neck, Volume 48, Issue 11, Page 3152-3172, November 2026.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell   +11 more
wiley   +1 more source

Membranous dysmenorrhea and decidual casts: A scoping review

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 175, Issue 2, Page 544-553, November 2026.
Abstract Background Membranous dysmenorrhea, characterized by the expulsion of intact endometrial tissue rather than gradual dissolution during menstruation, occasionally presents as a decidual cast—a complete triangular mold of the uterine cavity. This poorly understood condition is likely underdiagnosed.
Lovisa Brehmer, Hedvig Engberg
wiley   +1 more source

Renal Abscess Secondary to Urinary Tract Obstruction Caused by Pelvic Organ Prolapse: A Report of Two Cases

open access: yesIJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Pelvic organ prolapse can cause urinary tract obstruction, leading to hydronephrosis, pyelonephritis, and in rare cases, renal abscess. Case Presentation We report two elderly women with advanced pelvic organ prolapse who developed renal abscesses.
Hiroki Sai   +4 more
wiley   +1 more source

Implementing a national acute rheumatic fever case-finding program and registry in Nepal: protocol for a multi-site implementation study. [PDF]

open access: yesFront Cardiovasc Med
Klassen S   +13 more
europepmc   +1 more source

Old disease, new twist

open access: yesJournal of Hospital Medicine, Volume 21, Issue 11, Page 1305-1309, November 2026.
Abstract An 81‐year‐old man with a history of high‐grade urothelial carcinoma of the bladder and ureter on treatment with atezolizumab and tiragolumab presented to the emergency department with 5 months of malaise, generalized weakness, and fatigue and 2 weeks of subjective fevers. One month prior to presentation, he received an empiric 9‐day course of
Hadi Roudsari   +4 more
wiley   +1 more source

PhIP-Seq uncovers marked heterogeneity in acute rheumatic fever autoantibodies. [PDF]

open access: yesJCI Insight
McGregor R   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy